.

Neurocrine Biosciences reported $163.3M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
Acorda Therapeutics ACOR:US $ 23.13M 8.75M
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
ALKERMES ALKS:US $ 254.65M 27.91M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Amgen AMGN:US $ 5203M 1325M
Aptinyx Inc APTX:US $ 85.27M 14.89M
Biogen BIIB:US $ 2646.6M 897.3M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Cytokinetics CYTK:US $ 93.63M 21.79M
Dynavax Technologies DVAX:US $ 249.09M 69.67M
Enanta Pharmaceuticals ENTA:US $ 28.37M 12.62M
Exelixis EXEL:US $ 627M 96.27M
Gilead Sciences GILD:US $ 7000M 2704M
Halozyme Therapeutics HALO:US $ 90.93M 26.9M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
Intra Cellular Therapies ITCI:US $ 77.24M 52.06M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Prothena PRTA:US $ 508.8M 34.2M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Repligen RGEN:US $ 596.51M 11.87M
Rigel Pharmaceuticals RIGL:US $ 27.2M 2.52M
Sarepta Therapeutics SRPT:US $ 868.56M 365.31M
Teva Pharmaceutical TEVA:IT 2.06B 117M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M
YTE INCY:US $ 2435.38M 178.62M